Diabetes
Other Therapy Areas
Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore hormone replacement therapy
Medical Information | Non-US Health Care Professionals
Account Settings
Communication Preferences
Sign Out
Sign In | Create Account
  • Diabetes Home
    • Products
      Diabetes Treatments
    • Professional Resources
      Product Resources Library Insulin & Type 1 Diabetes
    • Professional Training
      Insulin Pen Training
  • Sample Requests
    • Diabetes Education
      Clinical Education Library Diabetes Risk Assessment Tool Diabetes & Cardiovascular Disease
    • Treatment Guidelines
      ADA Standards of Care AACE Diabetes Guidelines
    • Additional Resources
      Utilizing Your EHR Organizations & Conferences
    • Product Education
      Product Education Materials
    • Disease Education
      Disease Education Library
    • Prescription Savings & Coverage
      Savings Cards Insurance Coverage Affordability Resources
    • Support Program
      Diabetes Management Cardiovascular Risk Management
  • Sign In
    Create Account
    • Account Settings
    • Communication Preferences
    • Sign Out
    Other Therapy Areas
    Medical Information
    Non-US Health Care Professionals
Diabetes & Cardiovascular Disease
Diabetes & Cardiovascular Disease
  • Overview
  • Clinical Guidelines
  • Multidisciplinary Care
  • Talking to Patients

Talking to your patients with type 2 diabetes about cardiovascular disease

Actor portrayal

Curated facts and patient-friendly language may help patients with type 2 diabetes (T2D) appreciate the importance of their cardiovascular health and take a more active role in their treatment plan.

Setting context

Cardiovascular disease (CVD) is a general term for all types of conditions that affect the heart and blood vessels.1  

CVD associated conditions icon

CVD is associated with conditions like:

  • High blood pressurea
  • High LDL (bad) cholesterol and low HDL (good) cholesterolb
  • High triglycerides, a type of fat in the blood1,c  

People with type 2 diabetes are more likely to have these conditions.1  

cvd symptoms icon

CVD includes symptoms like:

  • Shortness of breath
  • Fatigue
  • Pain in the chest, throat, back, legs, neck, jaw, upper abdomen, or arms
  • Weakness or numbness in arms or legs2  

Many forms of CVD are called
atherosclerotic CVD (ASCVD), which
involves the buildup of plaque
in the body’s arteries.3  

Actor portrayal

serious problems ascvd can lead to icon

ASCVD can lead to serious problems like:

  • Stroke, which is when a blood vessel leading to the brain is either blocked or bursts4
  • Coronary heart disease, where plaque builds up in the heart’s arteries5
  • Peripheral artery disease (PAD), where plaque narrows arteries that carry blood to other parts of the body, such as the legs and feet5

aStage 1 hypertension is defined as systolic blood pressure of 130-139 mm Hg or diastolic blood pressure of 80-89 mm Hg.6  

bLow-density lipoprotein (LDL) contributes to fatty buildups in arteries, known as atherosclerosis. High-density lipoprotein (HDL) helps by carrying some LDL away from the arteries and into the liver, which processes it. A patient’s LDL number should not be the main factor in guiding treatment to prevent heart attack and stroke.7,8

cNormal triglyceride levels vary by age and sex.8

Communicating risk

Type 2 diabetes and cardiovascular disease often go hand in hand.

ASCVD is the #1 cause of death and disability among people with T2D9  

People with T2D have a 2–4x higher risk of stroke or heart attack vs. those without T2D10-12

Actor portrayal

ASCVD occurs 14.6 years earlier for people with T2D vs. people without T2D13  

Making a plan

Treatment options may include medications that treat diabetes and reduce CVD risk at the same time.

GLP-1 RA icon

What are the options?

GLP-1 RAs (glucagon-like peptide-1 receptor agonists) help the pancreas release more insulin when blood sugar is high, help prevent the liver from making and releasing too much sugar, and slow down food leaving the stomach.14

SGLT-2is (sodium-glucose cotransporter 2 inhibitors) help the body get rid of excess glucose by eliminating it in the urine.14

heart with check mark icon

What is their relationship to CVD?

Some GLP-1 RA products have helped prevent cardiovascular (CV) events like stroke and heart attack in patients with T2D, particularly those with established ASCVD.14

Many SGLT-2i products have helped prevent CV events, along with reducing the risk of hospitalization due to heart failure.14

Staying committed

You can share these brochures with patients to remind them of important information and steps they can take.

What is my risk of getting cardiovascular disease?
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
What is my risk of getting cardiovascular disease?
Information for your patients about the connection between type 2 diabetes and cardiovascular disease (CVD). Includes answers to commonly asked questions including what is CVD, risks, symptoms, and tests.
Download
Am I at risk for stroke?
PDF
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
Am I at risk for stroke?
Information for your patients about the connection between type 2 diabetes and stroke. Includes answers to commonly asked questions including what is a stroke, risk, and warning signs.
Download
Know Diabetes by Heart logo

Actor portrayal

Support program for diabetes patients with or at risk of ASCVD

The American Diabetes Association and the American Heart Association, along with Novo Nordisk and other industry leaders, have joined forces to create Know Diabetes by Heart™. This groundbreaking initiative provides a variety of resources to empower patients to better manage their risk for CVD, heart attacks, and strokes.

See program

References:

  1. Centers for Disease Control and Prevention. Diabetes and your heart. Reviewed May 7, 2021. Accessed February 28, 2022. https://www.cdc.gov/diabetes/library/features/diabetes-and-heart.html
  2. American Diabetes Association. Diabetes complications – Cardiovascular disease. Accessed February 28, 2022. https://www.diabetes.org/diabetes/cardiovascular-disease
  3. American Heart Association. What is cardiovascular disease? Reviewed May 31, 2017. Accessed March 4, 2022. https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease
  4. American Stroke Association. About stroke. Accessed February 28, 2022. https://www.stroke.org/en/about-stroke
  5. American Heart Association. Atherosclerosis. Accessed March 4, 2022. https://www.heart.org/en/health-topics/cholesterol/about-cholesterol/atherosclerosis
  6. American Heart Association. The facts about high blood pressure. Reviewed November 30, 2017. Accessed February 28, 2022. https://www.heart.org/en/health-topics/high-blood-pressure/the-facts-about-high-blood-pressure
  7. American Heart Association. Cholesterol: The good and the bad. Reviewed November 6, 2020. Accessed February 28, 2022. https://www.heart.org/en/health-topics/cholesterol/hdl-good-ldl-bad-cholesterol-and-triglycerides
  8. American Heart Association. Cholesterol and diabetes. Reviewed May 4, 2021. Accessed February 28, 2022. https://www.heart.org/en/health-topics/diabetes/diabetes-complications-and-risks/cholesterol-abnormalities--diabetes
  9. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016;133(24):2459-2502.
  10. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004;164(13):1422-1426.
  11. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA. 2004;292(20):2495-2499.
  12. Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014;5(4):444-470.
  13. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006;368:29–36.
  14. Das SR, Everett BM, Birtcher KK, et al. 2020 Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020;76(9):1117-1145.
Diabetes
Other Therapy Areas
Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore hormone replacement therapy
  • Diabetes Home
  • Product Information
    Products
    • Diabetes Treatments
    Professional Resources
    • Product Resources Library
      Insulin & Type 1 Diabetes
    Professional Training
    • Insulin Pen Training
  • Sample Requests
  • Professional Education
    Diabetes Education
    • Clinical Education Library
      Diabetes Risk Assessment Tool
      Diabetes & Cardiovascular Disease
    Treatment Guidelines
    • ADA Standards of Care
      AACE Diabetes Guidelines
    Additional Resources
    • Utilizing Your EHR
      Organizations & Conferences
  • Patient Support
    Product Education
    • Product Education Materials
    Disease Education
    • Disease Education Library
    Prescription Savings & Coverage
    • Savings Cards
      Insurance Coverage
      Affordability Resources
    Support Program
    • Diabetes Management
      Cardiovascular Risk Management

novoMEDLINK™ is a trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
Non-US Health Care Professionals, please go to pro.novonordisk.com.

Legal Notice | Privacy Policy | Cookie Policy | Contact Us |
novonordisk-us.com    
© 2022 Novo Nordisk All rights reserved. US22HCP00011 August 2022

Quick links

Request medication samples

Diabetes treatment guidelines

Patient savings card offer

Patient support program